Amerge

Active Ingredient(s): Naratriptan
FDA Approved: * February 10, 1998
Pharm Company: * GLAXOSMITHKLINE
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Amerge Overview

Naratriptan (trade names include Amerge and Naramig) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5mg tablets. It is a selective 5-HT1 receptor subtype agonist. Contents 1 Indication 2 Mechanism of action 3 Efficacy 4 Side effects 5 Exclusivity 6 References Indication Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches...

Read more Amerge Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Naratriptan

Recent Amerge Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Amerge: (2 results)

Sorted by National Drug Code

• 0173-0561 Amerge 1 mg Oral Tablet by Glaxosmithkline LLC
• 0173-0562 Amerge 2.5 mg Oral Tablet by Glaxosmithkline LLC

Other drugs which contain Naratriptan or a similar ingredient: (1 result)

• NARATRIPTAN 1 discussion